heat. | Health Evaluations + Applied Therapeutics is an independent informatics service devoted to providing intelligence and coverage on pricing and access to emerging Technologies-in-Health; primarily from a Pharmaceutical and Biotechnology perspective.

We serve as an informatics repository and an expert analysis hub on the global narrative on pricing, value and access to prescription drugs. heat. collects and collates information unavailable through any other single media source, continuously following discussions and debates while seeking to reflect a diverse community of views on issues of international importance.

This page has the following principal aims:

1. Debate on practices and policies pertaining to the valuation and pricing of biopharmaceuticals.

2. Insights on the assessment and impact of biopharmaceuticals.

3. Focus on access and affordability.

4. Promote a diversity of voices to ensure a balanced narrative.

5. Maintain a non-partisan environment to engage dialogue amongst healthcare stakeholders.

We want heat. to be a page that all stakeholders feel comfortable in visiting and engaging – to read, comment, and contribute – regardless of perspectives. People might not always “like” what we post, but everyone should feel invited and encouraged to join the discussion, share their opinions, and engage in debate.

heat. is committed to high journalistic standards of documentable evidence and reliable sourcing. This page does not have a single editorial position on specific issues but rather aims to build a diverse online community of views and opinions. Content shared on heat. represents the views of it’s authors and does not necessarily represent the opinions of the page or its editors.

heat. is non-profit, editorial-independent and dedicated to the public interest.